Kirk D - Search Results

1

Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group.

Bolger JJ, Dearnaley DP, Kirk D, Lewington VJ, Mason MD, Quilty PM, Reed NS, Russell JM, Yardley J. Bolger JJ, et al. Among authors: kirk d. Semin Oncol. 1993 Jun;20(3 Suppl 2):32-3. Semin Oncol. 1993. PMID: 7684863 Clinical Trial. No abstract available.

2

A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer.

Quilty PM, Kirk D, Bolger JJ, Dearnaley DP, Lewington VJ, Mason MD, Reed NS, Russell JM, Yardley J. Quilty PM, et al. Among authors: kirk d. Radiother Oncol. 1994 Apr;31(1):33-40. doi: 10.1016/0167-8140(94)90411-1. Radiother Oncol. 1994. PMID: 7518932 Clinical Trial.

3

Bilateral testicular cancer: a preventable problem? Experience from a large cancer centre.

Pamenter B, De Bono JS, Brown IL, Nandini M, Kaye SB, Russell JM, Yates AJ, Kirk D. Pamenter B, et al. Among authors: kirk d. BJU Int. 2003 Jul;92(1):43-6. doi: 10.1046/j.1464-410x.2003.04285.x. BJU Int. 2003. PMID: 12823381

4

Diagnosis and management of early prostate cancer. Report of a British association of urological surgeons working party.

Dearnaley dP, Kirby RS, Kirk D, Malone P, Simpson RJ, Wiliams G. Dearnaley dP, et al. Among authors: kirk d. BJU Int. 1999 Jan;83(1):18-33. doi: 10.1046/j.1464-410x.1999.00905.x. BJU Int. 1999. PMID: 10233447 Review. No abstract available.

5

The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancer.

Crawford ED, Kozlowski JM, Debruyne FM, Fair WR, Logothetis CJ, Balmer C, Robinson RG, Porter AT, Kirk D. Crawford ED, et al. Among authors: kirk d. Urology. 1994 Oct;44(4):481-5. doi: 10.1016/s0090-4295(94)80043-x. Urology. 1994. PMID: 7524233 Review. No abstract available.

6

Strontium-89 in the management of metastatic prostate cancer.

Kirk D. Kirk D. Cancer Surv. 1995;23:211-5. Cancer Surv. 1995. PMID: 7621459 Review.

7

Androgen receptors--a method to measure functional behaviour in human prostatic cancer.

Kirkali Z, Moffat LE, Leake R, Cowan S, Patel M, Kirk D. Kirkali Z, et al. Among authors: kirk d. Eur Urol. 1990;17(1):66-8. doi: 10.1159/000464003. Eur Urol. 1990. PMID: 2318242

8

Prostate cancer in the elderly.

Kirk D. Kirk D. Eur J Surg Oncol. 1998 Oct;24(5):379-83. doi: 10.1016/s0748-7983(98)92031-5. Eur J Surg Oncol. 1998. PMID: 9800964 Review.

9

Improved prognosis of patients with intermediate- and poor-risk nonseminomatous germ cell tumours by optimizing combined treatment.

Pentheroudakis G, De Bono JS, Kaye SB, Simpson A, Paul J, Brown I, Pamenter B, Kirk A, Vasey P, Raby N, Kirk D. Pentheroudakis G, et al. Among authors: kirk d, kirk a. BJU Int. 2003 Jul;92(1):36-42. doi: 10.1046/j.1464-410x.2003.04261.x. BJU Int. 2003. PMID: 12823380

10

Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).

de Bono JS, Paul J, Simpson A, Anthoney A, Kirk D, Underwood M, Graham J, Kaye SB. de Bono JS, et al. Among authors: kirk d. Br J Cancer. 2000 Aug;83(4):426-30. doi: 10.1054/bjoc.2000.1290. Br J Cancer. 2000. PMID: 10945485 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters